永久性心脏起搏器治疗缓慢性心律失常45例  

Permanent cardiac pacemaker treatment bradyarrythmia 45 patients

作　　者：董照辉[1] 周长高[1] 隋海燕[2] 

机构地区：[1]江苏省宿迁市沭阳县人民医院心内科,223600 [2]江苏省宿迁市沭阳县人民医院疼痛科,223600

出　　处：《中国临床实用医学》2009年第1期26-28,共3页China Clinical Practical Medicine

摘　　要：目的观察永久性心脏起搏器治疗缓慢性心律失常近中期疗效及安全性。方法自2004年2月至2008年6月，本院接受永久性心脏起搏器植入术45例，回顾分析患者资料。观察术后生理性起搏组（18例）与非生理性起搏组（27例）临床症状缓解情况、并发症、脑卒中、新发房颤、死亡等事件。结果两组患者术后症状明显改善。术后囊袋血肿2例。两组各1例发生脑梗死，脑卒中发生率差异无统计学意义（x^2=0．1962，P〉0．05）。两组均无新发房颤病例。非生理性起搏组死亡1例，死因心室颤动。结论永久性心脏起搏器治疗缓慢性心律失常可显著改善临床症状，提高生活质量，近中期较安全。Objective To observe the therapeutic effect and the security of permanent cardiac pacemaker on patients with bradyarrythmia in the near future and intermediate stage. Methods In total ,45 patients received permanent cardiac pacemaker were enrolled in this retrospective study, including unphysioligic pacing group（27 patients）and physioligic pacing group（ 18 patients）. The clinical symptomatic relief information,complication, stroks, atrial fibrillation and death were evaluated in two groups. Results After treatment, the clinical symptom were significantly improved in tow groups. 2 patients happened hematoma in sac after operations. There was 1 patient complicated with cerebral infarction in each group, and was no significant difference between two groups （X^2 = 0. 1962, P 〉 0. 05 ）. No atrial fibrillation happened after treatment. 1 patient from unphysioligic pacing group died of ventricular fibrillation. Conclusion Permanent cardiac pacemaker could be used efficiently and safely for patients with bradyarrythmia in the near future and intermediate stage, which can improve clinical symptom and raise quality of life.

关 键 词：永久性心脏起搏器 缓慢性心律失常 生理性起搏 非生理性起搏 

分 类 号：R541.7[医药卫生—心血管疾病]